↓ Skip to main content

Repurposed agents in the Alzheimer’s disease drug development pipeline

Overview of attention for article published in Alzheimer's Research & Therapy, August 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
11 X users

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Repurposed agents in the Alzheimer’s disease drug development pipeline
Published in
Alzheimer's Research & Therapy, August 2020
DOI 10.1186/s13195-020-00662-x
Pubmed ID
Authors

Justin Bauzon, Garam Lee, Jeffrey Cummings

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 114 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 14%
Student > Ph. D. Student 14 12%
Student > Master 10 9%
Student > Bachelor 6 5%
Other 4 4%
Other 15 13%
Unknown 49 43%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 16 14%
Medicine and Dentistry 11 10%
Biochemistry, Genetics and Molecular Biology 9 8%
Chemistry 8 7%
Neuroscience 5 4%
Other 14 12%
Unknown 51 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2023.
All research outputs
#1,379,240
of 25,271,884 outputs
Outputs from Alzheimer's Research & Therapy
#185
of 1,441 outputs
Outputs of similar age
#36,968
of 407,870 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#8
of 43 outputs
Altmetric has tracked 25,271,884 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,441 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 407,870 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.